Price
No data yet.
Social Signal Score
Revenue
$42.8KCompany Profile
- CEO
- Facundo Garreton
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 5
- Beta
- 2.65
- Country
- CA
- Piotroski score
- 3 / 9 (Weak)
- Altman Z-score
- -53.91
Financials
Revenue
$42.8K+822.6%Net Income
$-168.9KEBITDA
$-156.6KFree Cash Flow
$-14.0KEPS (diluted)
$-0.00Shares Outstanding (diluted)
495.09M+22478.4%Operating Expenses
$192.0KCash & Debt
$103.1KReturn of Capital
$0.00Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $312.0K | $-1.66M | $-0.00 |
| 2024 | $471.4K | $-1.15M | $-0.00 |
| 2023 | $288.3K | $-1.64M | $-0.01 |
| 2022 | $235.4K | $-1.47M | $-0.01 |
| 2021 | $138.7K | $-5.15M | $-0.03 |
| 2020 | $66.0K | $-4.94M | $-0.04 |
| 2019 | $0.00 | $-10.79M | $-0.10 |
| 2018 | $0.00 | $-15.5K | $-0.01 |
| 2017 | $0.00 | $-415.9K | $-0.19 |
| 2016 | $0.00 | $-132.6K | $-0.06 |
| 2015 | $0.00 | $-91.2K | $-0.04 |
| 2014 | $0.00 | $-430.0K | $-0.20 |
Valuation
BBRRFhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
90Social Signal Score
Mentions (1)
- Newsaccessnewswire.com·5h ago·Negative
…Medical Announces Closing of C$1.1 Million Non-Brokered Private Placement TORONTO, ON / ACCESS Newswire / August 26, 2026 / Blueberries Medical Corp. (CSE:BBM)(OTCID:BBRRF)(FRA:1OA) (the "Company" or "Blueberries"), a consumer science company focused on health, wellness and longevity, and a licensed producer of both psychoactive and non-psychoactive cannabis derivatives in Colombia, announces a non-brokered private placement consisting of the sale of 84,615,385 common shares ("Common Shares") at…
View source ↗
Earnings
Wed, Sep 2(in 6 days)
Estimates and results for BBRRF via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.